CrossrefInfokarte
A Phase I Clinical Trial of Trametinib in Combination with TAS-102 in Patients with Chemotherapy-Resistant RAS-Mutated (PIK3CA/PTEN-Wild Type) Metastatic Colorectal Cancer
Clinical Colorectal Cancer · 2022-09 · 21 (3) · 252-258
DOI: 10.1016/j.clcc.2022.05.004 ↗Abstract
Kein Abstract verfügbar.
EUVIMED